News
Important Only
Other
BRIEF-NKGen Biotech Announces Administration Of First Dose Of Troculeucel To Frontotemporal Dementia Patient Under FDA-Cleared Compassionate Use Program
Feb 21 (Reuters) - Nkgen Biotech Inc NKGN.O:NKGEN BIOTECH ANNOUNCES ADMINISTRATION OF FIRST DOSE OF TROCULEUCEL TO FRONTOTEMPORAL DEMENTIA PATIENT UNDER FDA-CLEARED COMPASSIONATE USE PROGRAMSource text: ID:nGNX96jCmYFurther company coverage: NKGN.OReuters
Fri, Feb 21
Other
BRIEF-Claritev Provides Oracle Cloud HCM Customers With Actionable Insights For Healthcare Cost Optimization And Plan Design
Feb 21 (Reuters) - Claritev Corp MPLN.N:CLARITEV PROVIDES ORACLE CLOUD HCM CUSTOMERS WITH ACTIONABLE INSIGHTS FOR HEALTHCARE COST OPTIMIZATION AND PLAN DESIGNSource text: ID:nBw28Fb4maFurther company coverage: MPLN.NReuters
Fri, Feb 21
Other
Guy Carp: Global cyber premiums reach ~$16.6 billion in 2024
By Michael LoneyFeb 13 - (The Insurer) - Global cyber market premiums grew to around $16.6 billion in 2024 with the bulk of business continuing to originate from North America, according to a report by Guy Carpenter.The reinsurance intermediary said that while North American carriers account for a s...Reuters
Fri, Feb 21
Other
Owens Corning expected to post earnings of $2.90 a share - Earnings Preview
Owens Corning OC.N, OC is expected to show a rise in quarterly revenue when it reports results on February 24 for the period ending December 31 2024The Toledo Ohio-based company is expected to report a 20.3% increase in revenue to $2.772 billion from $2.3 billion a year ago, according to the mean ...Reuters
Fri, Feb 21
Other
Kosmos Energy Ltd expected to post earnings of 1 cent a share - Earnings Preview
Kosmos Energy Ltd KOS.N, KOS is expected to show a fall in quarterly revenue when it reports results on February 24 for the period ending December 31 2024The Dallas Texas-based company is expected to report a 23.7% decrease in revenue to $387.353 million from $507.81 million a year ago, according ...Reuters
Fri, Feb 21
Other
BRIEF-Tiziana Life Sciences Announces Agreement For Product Development Services With Renaissance Lakewood, Llc
Feb 21 (Reuters) - Tiziana Life Sciences Ltd TLSA.O:TIZIANA LIFE SCIENCES ANNOUNCES AGREEMENT FOR PRODUCT DEVELOPMENT SERVICES WITH RENAISSANCE LAKEWOOD, LLCSource text: ID:nGNX38y3yFFurther company coverage: TLSA.OReuters
Fri, Feb 21
Other
BRIEF-Leidos Announces The Expiration And Results Of Cash Tender Offer For Any And All 3.625% Senior Notes Due 2025
Feb 21 (Reuters) - Leidos Holdings Inc LDOS.N:LEIDOS, INC. ANNOUNCES THE EXPIRATION AND RESULTS OF CASH TENDER OFFER FOR ANY AND ALL 3.625% SENIOR NOTES DUE 2025Source text: ID:nPncbr6FxaFurther company coverage: LDOS.NReuters
Fri, Feb 21
Stocks
Unity's Turnaround Is Slowly Taking Shape
Video game engine company Unity (NYSE: U) reported fourth-quarter results that should make investors squirm. Total revenue plunged 25% year over year, while revenue in the Create Solutions segment tumbled 47%. Even excluding the impact of the termination of a deal with Wētā FX, Create Solutions reve...The Motley Fool
Fri, Feb 21
Other
BRIEF-R&R REIT Issues Units To Trustees In Connection With 2024 Units For Services Agreements, Enters Into New Units For Services Agreements For 2025 And Issues Deferred Units To Executive Officers
Feb 21 (Reuters) - R&R Real Estate Investment Trust RRR_u.V:R&R REIT ISSUES UNITS TO TRUSTEES IN CONNECTION WITH 2024 UNITS FOR SERVICES AGREEMENTS, ENTERS INTO NEW UNITS FOR SERVICES AGREEMENTS FOR 2025 AND ISSUES DEFERRED UNITS TO EXECUTIVE OFFICERSSource text: ID:nCNWt8Q5paFurther company...Reuters
Fri, Feb 21
Stocks
Intra-Cellular Therapies Inc reports results for the quarter ended December 31 - Earnings Summary
Intra-Cellular Therapies Inc ITCI.OQ reported a quarterly adjusted loss of 16 cents per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -30 cents. The mean expectation of thirteen analysts for the quarter was for a loss of 11 cents...Reuters
Fri, Feb 21
Other
Itron Inc expected to post earnings of $1.05 a share - Earnings Preview
Itron Inc ITRI.OQ ITRI.O is expected to show a rise in quarterly revenue when it reports results on February 25 for the period ending December 31 2024The Liberty Lake Washington-based company is expected to report a 4.5% increase in revenue to $603.204 million from $577.17 million a year ago, acco...Reuters
Fri, Feb 21
Other
BRIEF-Neurocrine Biosciences Board Of Directors Authorizes $500 Million Share Repurchase Program
Feb 21 (Reuters) - Neurocrine Biosciences Inc NBIX.O:NEUROCRINE BIOSCIENCES BOARD OF DIRECTORS AUTHORIZES $500 MILLION SHARE REPURCHASE PROGRAMSource text: ID:nPn40SSL1aFurther company coverage: NBIX.OReuters
Fri, Feb 21
Other
BRIEF-Aditxt Co's Unit Pearsanta Engaged Dominari Securities Llc As Lead Underwriter For Pearsanta's Planned IPO
Feb 21 (Reuters) - Aditxt Inc ADTX.O:ADITXT: CO'S UNIT PEARSANTA ENGAGED DOMINARI SECURITIES LLC AS LEAD UNDERWRITER FOR PEARSANTA'S PLANNED IPOSource text: ID:nBw8T9LGLaFurther company coverage: ADTX.OReuters
Fri, Feb 21
